Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Take a survey on HIV cure research.
It’s just one episode of “HIV Matters,” a (free!) podcast series from the University of North Carolina’s Department of Medicine.
A recent study found that agents used to wake up resting HIV-infected cells probably work only on 5 percent of such cells.
Scientists tested the effects of the broadly neutralizing antibody PGT121 and the immune-stimulating agent GS-9620 in monkeys.
According to a pair of recent studies, meth was associated with certain HIV-related genetic and immune changes.
Scientists succeeded in editing the animals’ stem cells to resist an HIV-like virus and ultimately shrink their viral reservoir.
Researchers say CD32 is not a biomarker for immune cells latently infected with HIV but one for actively infected cells.
An update from the director of the Basic Science, Vaccines and Cure Project at Treatment Action Group (TAG).
For example: Hep C cures have meant fewer people to treat and fewer transmissions to potential patients.
Research shows that CAR-T cells could one day help cure HIV in humans.
Highlights from HIV and hepatitis C research presented at the 2018 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston
This finding stands in sharp contrast to a controversial 2016 paper that reached the opposite conclusion.
Sharon Lewin and Mark Dybul replace Jack Whitescarver and Françoise Barré-Sinoussi as cochairs of the advisory board.
The researchers studied a new compound that blocked a key viral protein that prompts infected cells to produce more virus.
Researchers discovered that higher levels of such cells were tied not only to infection risk but also HIV disease progression.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.